Form D · Biotechnology
X BODY INC
Waltham, MA · CIK 0001441394
Offering snapshot reported Apr 8, 2015 · SEC filing
- Reported sold
- $2.66M Offering amount: $3.96M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 12, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2015 | Initial | $2,662,465 | No comparison | 2 | SEC filing |
| Jan 23, 2012 | Amendment | $4,138,011 | $593,011vs Nov 8, 2011 | 1 | SEC filing |
| Nov 8, 2011 | Amendment | $3,545,000 | No comparison | 2 | SEC filing |
| Jan 6, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237544
Source: Form D, filed Apr 8, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brant Binder | Director, Executive |
| Gordon Binder | Director |
| Jeffrey Troderman | Executive |
| Richard W. Wagner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Beaver Street
Waltham, MA, 02453
Waltham, MA, 02453